rs7997
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003863.4(DPM2):āc.227C>Gā(p.Thr76Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.834 in 1,610,654 control chromosomes in the GnomAD database, including 567,414 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_003863.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPM2 | NM_003863.4 | c.227C>G | p.Thr76Ser | missense_variant | 4/4 | ENST00000314392.13 | NP_003854.1 | |
DPM2 | NM_001378437.1 | c.137C>G | p.Thr46Ser | missense_variant | 3/3 | NP_001365366.1 | ||
DPM2 | NR_165631.1 | n.384C>G | non_coding_transcript_exon_variant | 4/4 | ||||
DPM2 | NR_165632.1 | n.68C>G | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPM2 | ENST00000314392.13 | c.227C>G | p.Thr76Ser | missense_variant | 4/4 | 1 | NM_003863.4 | ENSP00000322181.8 |
Frequencies
GnomAD3 genomes AF: 0.787 AC: 119613AN: 151924Hom.: 47973 Cov.: 32
GnomAD3 exomes AF: 0.789 AC: 197919AN: 250700Hom.: 79920 AF XY: 0.791 AC XY: 107164AN XY: 135504
GnomAD4 exome AF: 0.839 AC: 1223461AN: 1458610Hom.: 519404 Cov.: 51 AF XY: 0.835 AC XY: 606011AN XY: 725692
GnomAD4 genome AF: 0.787 AC: 119698AN: 152044Hom.: 48010 Cov.: 32 AF XY: 0.783 AC XY: 58165AN XY: 74312
ClinVar
Submissions by phenotype
Congenital muscular dystrophy with intellectual disability and severe epilepsy Benign:4
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 15, 2013 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at